Predictors of persistence of use of the novel antidiabetic agent acarbose

Archives of Internal Medicine
V S CatalanJ LeLorier

Abstract

A carbose is the first of a new class of antidiabetic agents, the alpha-glucosidase inhibitors. This study characterizes and identifies predictors of persistence of use of acarbose. Medical, pharmaceutical, and demographic records were extracted for 2 cohorts of patients (social assistance recipients and seniors) from the databases of Quebec's provincial health plan. Patients were eligible for inclusion if they had received their first dispensation of acarbose between August 1, 1996, and December 31, 1997. The observation period included at least 1 year before the first dispensation and a minimum of 4 months after. New users of acarbose included 216 social assistance recipients and 677 seniors who were followed up for 82 914 and 270 041 person-days, respectively. Median persistence with acarbose treatment was 83 days (95% confidence interval, 75-105 days) for social assistance recipients and 105 days (95% confidence interval, 90-119 days) for seniors. In both cohorts, treatment by an endocrinologist vs another physician predicted longer treatment persistence. In the seniors cohort, additional determinants of (earlier) treatment discontinuation included a higher initial daily dose, previous treatment with insulin, and consultati...Continue Reading

Citations

May 2, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Haya Ascher-SvanumMichael Treglia
Feb 13, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Odile SheehyStéphane Rinfret
Mar 1, 2003·Epilepsy & Behavior : E&B·Joyce A. CramerVincent Rienzi
Mar 11, 2004·Journal of the American Academy of Nurse Practitioners·David Bartels
Dec 20, 2005·Journal of Clinical Epidemiology·Boris L G Van WijkAnthonius de Boer
Jun 13, 2015·Critical Reviews in Food Science and Nutrition·Amna TanveerAfshan Shafi
Nov 25, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joyce CramerUNKNOWN VA Naltrexone Study Group 425
Aug 12, 2004·Respiratory Medicine·N S Breekveldt-PostmaR M C Herings
Aug 22, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David S CobdenW Ken Redekop
Nov 9, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jean-Pierre GrégoireJocelyne Moisan
Apr 28, 2004·Diabetes Care·Joyce A Cramer
Dec 7, 2007·The Diabetes Educator·Peggy Soule Odegard, Kam Capoccia
Feb 1, 2009·Expert Review of Respiratory Medicine·J Lars G NilssonJanne Moen
Jul 21, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Thomas WilkeFrank Verheyen
Nov 7, 2019·Current Diabetes Reports·Christopher M MullaSamar Hafida
Jun 5, 2002·Current Opinion in Allergy and Clinical Immunology·Henry MilgromBruce Bender
Dec 24, 2010·Diabetes Technology & Therapeutics·Mark Peyrot, Richard R Rubin
Nov 11, 2020·Journal of Diabetes and Its Complications·Gustavo Monteiro EscottSandra Pinho Silveiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.